Purpose of the Study: Despite recent therapeutic advances, multiple myeloma (MM) remains incurable. Melflufen is a lipophilic peptide-conjugated alkylator that rapidly delivers a highly c...
Introduction:Achievement of minimal residual disease negativity (MRD–) status in multiple myeloma (MM) is associated with improved progression-free survival (PFS) and overall survival. ...
Introduction:The anti-CD38 antibody Isa in combination with Kd is approved in various countries for patients (pts) with relapsed MM after ‚â•1 prior therapy, based on primary interim anal...